A carregar...

Somatostatin receptor radionuclide therapy in neuroendocrine tumors

Peptide receptor radionuclide therapy (PRRT) using (177)Lu-DOTATATE has been approved for the treatment of gastroenteropancreatic NETs. An understanding of benefits and risks is important for the appropriate implementation of this therapy. This review summarizes study data supporting the use of radi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocr Relat Cancer
Main Authors: Haider, Mintallah, Das, Satya, Al-Toubah, Taymeyah, Pelle, Eleonora, El-Haddad, Ghassan, Strosberg, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118168/
https://ncbi.nlm.nih.gov/pubmed/33608483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0360
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!